This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fredericks, W. J. Articles by Rauscher, F. J. Search for Related Content PubMed PubMed Citation Articles by Fredericks, W. J. Articles by Rauscher, F. J., 3rd

 Previous Article  |  Next Article 

Mol. Cell. Biol., Mar 1995, 1522-1535, Vol 15, No. 3
Copyright © 1995, American Society for Microbiology

The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3

WJ Fredericks, N Galili, S Mukhopadhyay, G Rovera, J Bennicelli, FG Barr and FJ Rauscher 3rd
Wistar Institute, University of Pennsylvania School of Medicine, Philadelphia 19104.

Alveolar rhabdomyosarcomas are pediatric solid tumors with a hallmark cytogenetic abnormality: translocation of chromosomes 2 and 13 [t(2;13) (q35;q14)]. The genes on each chromosome involved in this translocation have been identified as the transcription factor-encoding genes PAX3 and FKHR. The NH2-terminal paired box and homeodomain DNA-binding domains of PAX3 are fused in frame to COOH-terminal regions of the chromosome 13-derived FKHR gene, a novel member of the forkhead DNA- binding domain family. To determine the role of the fusion protein in transcriptional regulation and oncogenesis, we identified the PAX3-FKHR fusion protein and characterized its function(s) as a transcription factor relative to wild-type PAX3. Antisera specific to PAX3 and FKHR were developed and used to examine PAX3 and PAX3-FKHR expression in tumor cell lines. Sequential immunoprecipitations with anti-PAX3 and anti-FKHR sera demonstrated expression of a 97-kDa PAX3-FKHR fusion protein in the t(2;13)-positive rhabdomyosarcoma Rh30 cell line and verified that a single polypeptide contains epitopes derived from each protein. The PAX3-FKHR protein was localized to the nucleus in Rh30 cells, as was wild-type PAX3, in t(2;13)-negative A673 cells. In gel shift assays using a canonical PAX binding site (e5 sequence), we found that DNA binding of PAX3-FKHR was significantly impaired relative to that of PAX3 despite the two proteins having identical PAX DNA-binding domains. However, the PAX3-FKHR fusion protein was a much more potent transcriptional activator than PAX3 as determined by transient cotransfection assays using e5-CAT reporter plasmids. The PAX3-FKHR protein may function as an oncogenic transcription factor by enhanced activation of normal PAX3 target genes.

This article has been cited by other articles:

• Ren, Y.-X., Finckenstein, F. G., Abdueva, D. A., Shahbazian, V., Chung, B., Weinberg, K. I., Triche, T. J., Shimada, H., Anderson, M. J. (2008). Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations. Cancer Res. 68: 6587-6597 [Abstract] [Full Text]  
• Roeb, W., Boyer, A., Cavenee, W. K., Arden, K. C. (2007). PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. Proc. Natl. Acad. Sci. USA 104: 18085-18090 [Abstract] [Full Text]  
• Gastaldi, T., Bonvini, P., Sartori, F., Marrone, A., Iolascon, A., Rosolen, A. (2006). Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. Carcinogenesis 27: 1758-1767 [Abstract] [Full Text]  
• Au, A. Y. M., McBride, C., Wilhelm, K. G. Jr., Koenig, R. J., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B. G., Clifton-Bligh, R. J. (2006). PAX8-Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Disrupts Normal PAX8 or PPAR{gamma} Transcriptional Function and Stimulates Follicular Thyroid Cell Growth. Endocrinology 147: 367-376 [Abstract] [Full Text]  
• Nabarro, S., Himoudi, N., Papanastasiou, A., Gilmour, K., Gibson, S., Sebire, N., Thrasher, A., Blundell, M. P., Hubank, M., Canderan, G., Anderson, J. (2005). Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. J. Exp. Med. 202: 1399-1410 [Abstract] [Full Text]  
• Bois, P. R.J., Izeradjene, K., Houghton, P. J., Cleveland, J. L., Houghton, J. A., Grosveld, G. C. (2005). FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. J. Cell Biol. 170: 903-912 [Abstract] [Full Text]  
• Shazand, K., Baban, S., Prive, C., Malette, B., Croteau, P., Lagace, M., Racine, J.-B., Hugo, P. (2004). FOXO1 and c-jun transcription factors mRNA are modulated in endometriosis. Mol Hum Reprod 10: 871-877 [Abstract] [Full Text]  
• Pisarska, M. D., Bae, J., Klein, C., Hsueh, A. J. W. (2004). Forkhead L2 Is Expressed in the Ovary and Represses the Promoter Activity of the Steroidogenic Acute Regulatory Gene. Endocrinology 145: 3424-3433 [Abstract] [Full Text]  
• Sebire, N J, Malone, M (2003). Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J. Clin. Pathol. 56: 412-416 [Abstract] [Full Text]  
• Kortylewski, M., Feld, F., Kruger, K.-D., Bahrenberg, G., Roth, R. A., Joost, H.-G., Heinrich, P. C., Behrmann, I., Barthel, A. (2003). Akt Modulates STAT3-mediated Gene Expression through a FKHR (FOXO1a)-dependent Mechanism. J. Biol. Chem. 278: 5242-5249 [Abstract] [Full Text]  
• Zhang, L., Wang, C. (2003). PAX3-FKHR Transformation Increases 26 S Proteasome-dependent Degradation of p27Kip1, a Potential Role for Elevated Skp2 Expression. J. Biol. Chem. 278: 27-36 [Abstract] [Full Text]  
• Armoni, M., Quon, M. J., Maor, G., Avigad, S., Shapiro, D. N., Harel, C., Esposito, D., Goshen, Y., Yaniv, I., Karnieli, E. (2002). PAX3/Forkhead Homolog in Rhabdomyosarcoma Oncoprotein Activates Glucose Transporter 4 Gene Expression in Vivo and in Vitro. J. Clin. Endocrinol. Metab. 87: 5312-5324 [Abstract] [Full Text]  
• Peng, H., Zheng, L., Lee, W.-H., Rux, J. J., Rauscher, F. J. III (2002). A Common DNA-binding Site for SZF1 and the BRCA1-associated Zinc Finger Protein, ZBRK1. Cancer Res. 62: 3773-3781 [Abstract] [Full Text]  
• Sorensen, P. H.B., Lynch, J. C., Qualman, S. J., Tirabosco, R., Lim, J. F., Maurer, H. M., Bridge, J. A., Crist, W. M., Triche, T. J., Barr, F. G. (2002). PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children's Oncology Group. JCO 20: 2672-2679 [Abstract] [Full Text]  
• Christian, M., Zhang, X., Schneider-Merck, T., Unterman, T. G., Gellersen, B., White, J. O., Brosens, J. J. (2002). Cyclic AMP-induced Forkhead Transcription Factor, FKHR, Cooperates with CCAAT/Enhancer-binding Protein beta in Differentiating Human Endometrial Stromal Cells. J. Biol. Chem. 277: 20825-20832 [Abstract] [Full Text]  
• Wiggan, O'N., Fadel, M. P., Hamel, P. A. (2002). Pax3 induces cell aggregation and regulates phenotypic mesenchymal-epithelial interconversion. J. Cell Sci. 115: 517-529 [Abstract] [Full Text]  
• Anderson, J., Ramsay, A., Gould, S., Pritchard-Jones, K. (2001). PAX3-FKHR Induces Morphological Change and Enhances Cellular Proliferation and Invasion in Rhabdomyosarcoma. Am. J. Pathol. 159: 1089-1096 [Abstract] [Full Text]  
• Anderson, M. J., Shelton, G. D., Cavenee, W. K., Arden, K. C. (2001). Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. Proc. Natl. Acad. Sci. USA 98: 1589-1594 [Abstract] [Full Text]  
• Ayyanathan, K., Fredericks, W. J., Berking, C., Herlyn, M., Balakrishnan, C., Gunther, E., Rauscher, F. J. III (2000). Hormone-dependent Tumor Regression in Vivo by an Inducible Transcriptional Repressor Directed at the PAX3-FKHR Oncogene. Cancer Res. 60: 5803-5814 [Abstract] [Full Text]  
• Fredericks, W. J., Ayyanathan, K., Herlyn, M., Friedman, J. R., Rauscher, F. J. III (2000). An Engineered PAX3-KRAB Transcriptional Repressor Inhibits the Malignant Phenotype of Alveolar Rhabdomyosarcoma Cells Harboring the Endogenous PAX3-FKHR Oncogene. Mol. Cell. Biol. 20: 5019-5031 [Abstract] [Full Text]  
• Cao, Y., Wang, C. (2000). The COOH-terminal Transactivation Domain Plays a Key Role in Regulating the in Vitro and in Vivo Function of Pax3 Homeodomain. J. Biol. Chem. 275: 9854-9862 [Abstract] [Full Text]  
• Tomizawa, M., Kumar, A., Perrot, V., Nakae, J., Accili, D., Rechler, M. M. (2000). Insulin Inhibits the Activation of Transcription by a C-terminal Fragment of the Forkhead Transcription Factor FKHR. A MECHANISM FOR INSULIN INHIBITION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 TRANSCRIPTION. J. Biol. Chem. 275: 7289-7295 [Abstract] [Full Text]  
• Ye, H., Holterman, A. X., Yoo, K. W., Franks, R. R., Costa, R. H. (1999). Premature Expression of the Winged Helix Transcription Factor HFH-11B in Regenerating Mouse Liver Accelerates Hepatocyte Entry into S Phase. Mol. Cell. Biol. 19: 8570-8580 [Abstract] [Full Text]  
• Kempf, B. E., Vogt, P. K. (1999). A Genetic Analysis of PAX3-FKHR, the Oncogene of Alveolar Rhabdomyosarcoma. Cell Growth Differ. 10: 813-818 [Abstract] [Full Text]  
• Khan, J., Bittner, M. L., Saal, L. H., Teichmann, U., Azorsa, D. O., Gooden, G. C., Pavan, W. J., Trent, J. M., Meltzer, P. S. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96: 13264-13269 [Abstract] [Full Text]  
• Cohn, S. L. (1999). Diagnosis and Classification of the Small Round-Cell Tumors of Childhood. Am. J. Pathol. 155: 11-15 [Full Text]  
• Nakae, J., Park, B.-C., Accili, D. (1999). Insulin Stimulates Phosphorylation of the Forkhead Transcription Factor FKHR on Serine 253 through a Wortmannin-sensitive Pathway. J. Biol. Chem. 274: 15982-15985 [Abstract] [Full Text]  
• Ryan, R. F., Schultz, D. C., Ayyanathan, K., Singh, P. B., Friedman, J. R., Fredericks, W. J., Rauscher, F. J. III (1999). KAP-1 Corepressor Protein Interacts and Colocalizes with Heterochromatic and Euchromatic HP1 Proteins: a Potential Role for Kruppel-Associated Box-Zinc Finger Proteins in Heterochromatin-Mediated Gene Silencing. Mol. Cell. Biol. 19: 4366-4378 [Abstract] [Full Text]  
• Li, J, Liu, K., Jin, F, Lu, M., Epstein, J. (1999). Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126: 2495-2503 [Abstract]  
• Amthor, H, Christ, B, Patel, K (1999). A molecular mechanism enabling continuous embryonic muscle growth - a balance between proliferation and differentiation. Development 126: 1041-1053 [Abstract]  
• Lam, P. Y. P., Sublett, J. E., Hollenbach, A. D., Roussel, M. F. (1999). The Oncogenic Potential of the Pax3-FKHR Fusion Protein Requires the Pax3 Homeodomain Recognition Helix but Not the Pax3 Paired-Box DNA Binding Domain. Mol. Cell. Biol. 19: 594-601 [Abstract] [Full Text]  
• Reeves, F., Burdge, G., Fredericks, W., Rauscher, F., Lillycrop, K. (1999). Induction of antisense Pax-3 expression leads to the rapid morphological differentiation of neuronal cells and an altered response to the mitogenic growth factor bFGF. J. Cell Sci. 112: 253-261 [Abstract]  
• Morrison, A. M., Jager, U., Chott, A., Schebesta, M., Haas, O. A., Busslinger, M. (1998). Deregulated PAX-5 Transcription From a Translocated IgH Promoter in Marginal Zone Lymphoma. Blood 92: 3865-3878 [Abstract] [Full Text]  
• Phelan, S. A., Loeken, M. R. (1998). Identification of a New Binding Motif for the Paired Domain of Pax-3 and Unusual Characteristics of Spacing of Bipartite Recognition Elements on Binding and Transcription Activation. J. Biol. Chem. 273: 19153-19159 [Abstract] [Full Text]  
• Epstein, J. A., Song, B., Lakkis, M., Wang, C. (1998). Tumor-Specific PAX3-FKHR Transcription Factor, but Not PAX3, Activates the Platelet-Derived Growth Factor Alpha Receptor. Mol. Cell. Biol. 18: 4118-4130 [Abstract] [Full Text]  
• Tang, H. K., Singh, S., Saunders, G. F. (1998). Dissection of the Transactivation Function of the Transcription Factor Encoded by the Eye Developmental Gene PAX6. J. Biol. Chem. 273: 7210-7221 [Abstract] [Full Text]  
• Massuda, E. S., Dunphy, E. J., Redman, R. A., Schreiber, J. J., Nauta, L. E., Barr, F. G., Maxwell, I. H., Cripe, T. P. (1997). Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells. Proc. Natl. Acad. Sci. USA 94: 14701-14706 [Abstract] [Full Text]  
• Davis, R. J., Barr, F. G. (1997). Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 94: 8047-8051 [Abstract] [Full Text]  
• Overdier, D. G., Ye, H., Peterson, R. S., Clevidence, D. E., Costa, R. H. (1997). The Winged Helix Transcriptional Activator HFH-3 Is Expressed in the Distal Tubules of Embryonic and Adult Mouse Kidney. J. Biol. Chem. 272: 13725-13730 [Abstract] [Full Text]  
• Lim, L., Zhou, H., Costa, R. H. (1997). The winged helix transcription factor HFH-4 is expressed during choroid plexus epithelial development in the mouse embryo. Proc. Natl. Acad. Sci. USA 94: 3094-3099 [Abstract] [Full Text]  
• Bernasconi, M., Remppis, A., Fredericks, W. J., Rauscher, F. J. III, Schafer, B. W. (1996). Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc. Natl. Acad. Sci. USA 93: 13164-13169 [Abstract] [Full Text]  
• Sutton, J., Costa, R., Klug, M., Field, L., Xu, D., Largaespada, D. A., Fletcher, C. F., Jenkins, N. A., Copeland, N. G., Klemsz, M., Hromas, R. (1996). Genesis, a Winged Helix Transcriptional Repressor with Expression Restricted to Embryonic Stem Cells. J. Biol. Chem. 271: 23126-23133 [Abstract] [Full Text]  
• Friedman, J R, Fredericks, W J, Jensen, D E, Speicher, D W, Huang, X P, Neilson, E G, Rauscher, F J (1996). KAP-1, a novel corepressor for the highly conserved KRAB repression domain.. Genes Dev. 10: 2067-2078 [Abstract]  
• Hellqvist, M., Mahlapuu, M., Samuelsson, L., Enerbäck, S., Carlsson, P. (1996). Differential Activation of Lung-specific Genes by Two Forkhead Proteins, FREAC-1 and FREAC-2. J. Biol. Chem. 271: 4482-4490 [Abstract] [Full Text]  
• Latchman, D. S. (1996). Transcription-Factor Mutations and Disease. NEJM 334: 28-33 [Full Text]  
• Peng, H., Begg, G. E., Harper, S. L., Friedman, J. R., Speicher, D. W., Rauscher, F. J. III (2000). Biochemical Analysis of the Kruppel-associated Box (KRAB) Transcriptional Repression Domain. SPECTRAL, KINETIC, AND STOICHIOMETRIC PROPERTIES OF THE KRAB{middle dot}KAP-1 COMPLEX. J. Biol. Chem. 275: 18000-18010 [Abstract] [Full Text]  
• Zhao, H. H., Herrera, R. E., Coronado-Heinsohn, E., Yang, M. C., Ludes-Meyers, J. H., Seybold-Tilson, K. J., Nawaz, Z., Yee, D., Barr, F. G., Diab, S. G., Brown, P. H., Fuqua, S. A. W., Osborne, C. K. (2001). Forkhead Homologue in Rhabdomyosarcoma Functions as a Bifunctional Nuclear Receptor-interacting Protein with Both Coactivator and Corepressor Functions. J. Biol. Chem. 276: 27907-27912 [Abstract] [Full Text]  
• Schuur, E. R., Loktev, A. V., Sharma, M., Sun, Z., Roth, R. A., Weigel, R. J. (2001). Ligand-dependent Interaction of Estrogen Receptor-alpha with Members of the Forkhead Transcription Factor Family. J. Biol. Chem. 276: 33554-33560 [Abstract] [Full Text]